Climb Bio CLYM Income Statement (2020-2026)

NASDAQ CLYM
$15.60 +1.01 (+6.92%)
As of: Sep 4, 2026 · 12:50 PM EDT
Reported Financials

Climb Bio Quarterly Income Statement

Periods 25 quarters
Latest Jun 2026

Climb Bio reported net income of -$13.72M for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
15.59M12.26M26.57M26.57M26.57M26.57M26.97M26.99M27.47M27.70M27.72M30.35M67.22M48.16M67.58M67.76M68.18M67.81M68.21M76.15M
Operating items
Research & DevelopmentR&D
5.99M6.88M8.26M8.77M4.26M4.93M5.72M3.69M2.88M3.13M1.09M1.05M6.24M5.96M17.33M6.58M9.07M13.74M9.37M9.71M
Selling, General & AdministrativeSG&A
3.39M3.82M4.87M4.93M4.49M4.63M17.72M3.03M2.12M2.00M1.91M3.67M5.49M4.95M5.69M4.10M5.82M5.56M5.84M5.64M
Restructuring CostsRestructuring
15.79M0.73M0.22M2.07M3.34M
Other Operating ExpensesOther Opex
0.02M0.06M0.09M0.90M-0.73M-0.22M-2.07M51.66M-3.34M
Operating ExpensesOpex
9.38M10.70M13.13M13.70M8.75M9.55M23.44M6.71M5.00M5.12M3.00M56.37M11.73M10.91M23.02M10.68M14.89M19.30M15.21M15.36M
Operating IncomeOp. Inc
-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M-15.36M
EBIT
-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M-15.36M
Non-operating items
Non Operating Investment Income
0.02M-0.10M-0.40M-0.08M0.02M0.22M0.26M0.06M0.02M0.01M0.00M0.20M-0.18M0.26M0.03M0.15M-0.03M-0.28M-0.22M
Interest & Investment IncomeInt & Inv Inc
0.15M0.38M0.76M0.90M1.11M1.26M1.35M1.34M1.49M2.79M2.52M2.29M2.17M2.04M1.83M1.51M1.85M
Other Non Operating IncomeOther Non Op Inc.
-0.23M0.16M-0.16M-0.90M-0.93M1.79M1.15M1.49M1.03M1.48M1.31M-0.00M0.05M8.11M-0.05M-0.16M-0.03M8.28M-0.03M0.01M
Non Operating IncomeNon Op. Inc.
1.48M2.84M2.24M2.01M2.00M1.49M1.86M
Net income details
EBT
-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M-13.50M
Profit After TaxPAT
-9.63M-10.65M-13.60M-14.68M-9.68M-7.54M-22.29M-5.22M-3.97M-3.64M-1.70M-54.89M-8.89M-8.42M-20.78M-8.67M-12.89M-17.52M-13.72M-13.72M
Income from Non-Controlling InterestsInc. Minority
-9.63M-10.65M-13.60M
Income from Continuing OperationsIncome (Continuing)
-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M-13.50M
Consolidated Net IncomeConsol Net Inc.
-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M-13.50M
Income towards Parent CompanyParent Net Inc
-9.38M-10.70M-13.13M-13.55M-8.37M-8.79M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M-13.50M
Preferred Dividend PaymentsPref Dividends
1.32M
Net Income towards Common StockholdersNet Income
-10.94M-10.54M-13.20M-14.60M-9.68M-7.76M-22.54M-5.60M-3.74M-3.77M-1.66M-54.89M-8.95M-8.39M-20.73M-8.50M-12.86M-17.47M-13.70M-13.50M
Additional items
EPS (Basic)
-0.70-0.86-0.50-0.56-0.37-0.30-0.85-0.21-0.14-0.14-0.06-1.81-0.13-0.17-0.31-0.13-0.19-0.26-0.20-0.18
EPS (Diluted)
-0.70-0.86-0.50-0.56-0.37-0.30-0.85-0.21-0.14-0.14-0.06-1.81-0.13-0.17-0.31-0.13-0.19-0.26-0.20-0.18
Shares Outstanding
15.59M12.26M26.24M26.30M26.34M26.31M26.49M26.84M27.07M26.99M27.64M30.35M67.01M48.16M67.46M67.59M68.00M67.81M68.21M76.15M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
15.59M12.26M26.24M26.30M26.34M26.31M26.49M26.84M27.07M26.99M27.64M30.35M67.01M48.16M67.46M67.59M68.00M67.81M68.21M76.15M
EBITDA
-9.38M-10.70M-13.13M-13.70M-8.75M-9.55M-23.44M-6.71M-5.00M-5.12M-3.00M-56.37M-11.73M-10.91M-23.02M-10.68M-14.89M-19.30M-15.21M-15.36M